Discover the signs of psoriatic arthritis, from joint pain and skin changes to nail damage and fatigue, plus the latest treatment options for this condition.

Unmanaged diabetes can lead to amputations, usually of the toes, feet, or legs. Causes include reduced blood flow or peripheral neuropathy. Managing your blood sugar may help prevent it. Limb loss ...

Johnson & Johnson (J&J) has shared positive results from a phase 3b study of Tremfya (guselkumab) in adults with psoriatic arthritis (PsA). The APEX trial has been comparing the drug against placebo ...

Initially disclosing a diagnosis of rheumatoid arthritis, he later revealed that he actually suffers from psoriatic arthritis - a chronic condition characterised by joint pain, swelling and ...

The significance of diet in managing arthritis has been emphasised by experts, who have provided guidance on what to consume to alleviate pain and inflammation. The Mediterranean diet, renowned ...

Novak Djokovic and Casper Ruud will play their first Monte Carlo Masters matches on Wednesday. The Serb is facing Alejandro Tabilo in the second round while the Norwegian awaits the winner of the ...

Among a large cohort of young adults with psoriatic arthritis, 38.8% exhibited radiographic evidence of degenerative disc disease. Researchers in Canada conducted a retrospective cohort study to ...

in limiting structural damage in patients with active psoriatic arthritis (PsA). The FDA approved guselkumab for adult patients with active PsA in July 2020. 2 This made it the first and only ...

CASPER, Wyo. — Just over a month away from his 17th birthday, Casper teen Eavan Castaner was sentenced to 42–75 years in prison for fatally shooting his ex-girlfriend, Lene’a Brown, on the night of ...

In today’s fast-paced world where stress, anxiety, and burnout have become all too common, the importance of creating a home that nurtures mental health cannot be overstated. Our homes are more ...

US-based pharmaceutical company Johnson & Johnson (J&J) has reported positive results from a Phase IIIb trial of its monoclonal antibody Tremfya (guselkumab) for active psoriatic arthritis (PsA).

Psoriatic arthritis represents a complex intersection of immune dysfunction where inflammation targets both skin and joints, creating a condition that challenges patients and clinicians alike.